👋 New here? A quick tour of the page
Filter the analysis to a single sector, or stay on the first tab for the full market scan.
Stocks ranked by number of positive mentions, then average sentiment. Open "Why is it moving?" on any card to read the exact headlines behind the score β each one links to its original article.
Use the sidebar search to look up any tracked ticker or company name and see its bullish and bearish headlines side by side.
Hit Refresh Analysis to re-scan the latest news, or add your own RSS feed in the sidebar to include it in the scan.
Pharma stocks: news sentiment today
Ranked by number of positive news mentions, then by average VADER sentiment score. How it works
Why is LLY moving?
▲ Why it may be rising
- Nasdaq Prediction: $10,000 Equally Split Between Eli Lilly and Novo Nordisk Will Be Worth This Much by the End of 2027 Key PointsEli Lilly is surging, with revenue upβ¦
- Nasdaq Calytrix Bio To Be Bought By Lilly In Up To $1.5 Bln Cash Deal (RTTNews) - Calytrix Bio, Inc., a biotechnology company focused on myeloproliferative neoplasms oβ¦
- Yahoo Finance Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know Lilly (LLY) has been one of the stocks most watched by Zacks.com userβ¦
Why is PFE moving?
▲ Why it may be rising
- Nasdaq 2 Bargain Stocks to Buy With $1,000 in November Key PointsDrugmaker Pfizer has a brighter future than its stock’s recent performance suggests. You just neβ¦
- Nasdaq Pfizer's 5.9% Yield vs. AbbVie's 53-Year Dividend Streak: Which Stock Is the Better Buy? Key PointsPfizer offers one of the highest yields in healthcare.
- Nasdaq 5 Dividend Stocks With High Yields That Are Safer Than You Might Think Key PointsPfizer and Bristol Myers Squibb are facing normal industry headwinds in the druβ¦
Why is JNJ moving?
▲ Why it may be rising
- Nasdaq Johnson & Johnson Set To Buy Ollin Biosciences For Up To $3.4 Bln: Report (RTTNews) - Johnson & Johnson (JNJ) is close to acquiring eye disease drug developer Oβ¦
- Nasdaq Johnson & Johnson To Acquire Ollin Biosciences In $2.2 Bln Deal (RTTNews) - Healthcare company Johnson & Johnson (JNJ) announced on Monday that it has agreed toβ¦
- Nasdaq Johnson & Johnson vs. Novo Nordisk: Steady Uptrend vs. Flat Revenue Key PointsJohnson & Johnson currently exhibits a stronger overall position by generatingβ¦
Why is MRK moving?
▲ Why it may be rising
- fool.com Is Merck's Stock Still a Good Buy at $150? The healthcare stock has surged nearly 40% this year.
- Nasdaq Is Merck's Stock Still a Good Buy at $150? Key PointsMerck is coming off a strong quarter as revenue from a new version of Keytruda boosted its top line.
- Nasdaq Broker Darlings of the Dow: Merck Ranks As a Top 15 Analyst Pick A study of analyst recommendations at the major brokerages shows that Merck & Co Inc (Symboβ¦
▼ Why it may be falling
- Investing.com European panel backs Merck RSV drug for second season use
- MarketWatch The science of vaccines is rapidly advancing β despite the anti-vax movement Look at the promising data for Moderna and Merckβs experimental cancer vaccine andβ¦
- trefis.com Merck Stock's $1.3 Billion China Problem Goes Quiet Today's big story: Could Nvidia Stock Fall 50%? Follow The Cash.
Why is MRNA moving?
▲ Why it may be rising
- trefis.com The Single Most Important Metric For Moderna Stock For questions about this article or underlying research, email help@trefis.com.
- Investing.com Moderna chief legal officer to retire, transitional agreement details compensation
- Nasdaq Axsome Therapeutics vs. Moderna: Which Biotech Innovator Stock Is a Better Buy for 2027? Key PointsAxsome Therapeutics is experiencing rapid revenue growth drivβ¦
▼ Why it may be falling
- MarketWatch The science of vaccines is rapidly advancing β despite the anti-vax movement Look at the promising data for Moderna and Merckβs experimental cancer vaccine andβ¦
- tikr.com Moderna Sinks 12% in a Week. Bancel Wants an FDA Filing βBefore the End of the Yearβ Key TakeawaysModerna fell 12% in the week to Nov. 13 after guiding to aboutβ¦
- Nasdaq Is Moderna's Cancer Vaccine a Game Changer for the Stock? Key PointsIntismeran and Keytruda have demonstrated in clinical trials that they can drastically improβ¦
Why is BMY moving?
▲ Why it may be rising
- Nasdaq Bristol Myers Squibb's Growth Portfolio Now Brings In $7.7 Billion a Quarter. Here's Why That Changes the Stock's Story. Key PointsBristol Myers Squibb is a larβ¦
- Nasdaq 5 Dividend Stocks With High Yields That Are Safer Than You Might Think Key PointsPfizer and Bristol Myers Squibb are facing normal industry headwinds in the druβ¦
- Investing.com Bristol Myers Squibb shares preliminary KarXT trial data
Why is BIIB moving?
Why is AMGN moving?
▲ Why it may be rising
- Nasdaq AMGN February 2027 Options Begin Trading Investors in Amgen Inc (Symbol: AMGN) saw new options become available today, for the February 2027 expiration. One ofβ¦
- Nasdaq Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027? Key PointsAmgen maintains a massive global footprint and a highly diversifiedβ¦
Why is AZN moving?
▲ Why it may be rising
- Investing.com AstraZeneca gets U.S. approval for two drugs
Why is GILD moving?
▲ Why it may be rising
📰 Data sources Stock prices via Yahoo Finance. News headlines from Yahoo Finance, The Wall Street Journal, CNBC, MarketWatch, The New York Times, BBC, The Guardian, Financial Times, The Economist, Associated Press, Seeking Alpha, The Motley Fool, Benzinga, Forbes, Financial Post, Fortune, Business Insider, Investing.com, Nasdaq, CNN Business, TechCrunch, The Verge, Ars Technica, Wired, Engadget, VentureBeat, The Register, CoinDesk, Cointelegraph, Google News, ZeroHedge, and Reddit β each headline links to its original article, with the source publication tagged alongside it.